Jusvinza treatment resolution in confirmed COVID-19 patients. Santiago de Cuba, 2021
<strong>Foundation</strong>: SARS-CoV-2 infection is the most important emerging disease of this century. In this context, the Cuban Biotechnology and Pharmaceutical Industries Group (BioCubaFarma) created therapeutic alternatives to combat COVID-19, including the use of Jusvinza, which...
Main Authors: | Sandra Caridad Laurencio Vallina, Martha María Arias Carbonell, Leonardo Ramos Hechavarría, Dayami Lescay Balanquet, Roger Pina Núñez |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos
2024-02-01
|
Series: | Medisur |
Subjects: | |
Online Access: | http://medisur.sld.cu/index.php/medisur/article/view/45089 |
Similar Items
-
Caracterización clínico-epidemiológica del cáncer de ovario
by: Hailyn González Fernández, et al.
Published: (2021-12-01) -
Morbilidad y mortalidad materna en una institución de salud en el año 2012
by: Cecilia E. Guerra Gutiérrez, et al.
Published: (2014-01-01) -
Risk Factors for Stroke-associated Pneumonia: A Prospective Cohort Study
by: Alexis Suárez Quesada, et al.
Published: (2015-12-01) -
Risk Factors for Stroke-associated Pneumonia: A Prospective Cohort Study
by: Alexis Suárez Quesada, et al.
Published: (2015-12-01) -
Severe Diabetic Gastroparesis: Diagnosis by Ruling out of Constitutional Syndrome in an Older Adult: a Case Report
by: Vianey Guadalupe Téllez Bolaños, et al.
Published: (2023-05-01)